Contact l Sitemap

home industries issues reasearch weblog press

Home  » Industries » Pharmaceuticals

Pharmaceuticals

The cost of prescription drugs has never been higher, and pharmaceutical companies have never spent more persuading consumers that they need drugs they've never heard of for illnesses they didn't know they had. Drug companies are also spending millions defending patents and persuading the FDA to approve new drugs ever faster. Meanwhile, developing countries go without desperately needed drugs because pharmaceutical companies fear that lowering prices for the neediest is a slippery slope. Big Pharma says high prices fund research and innovation.


News Articles

US: Online Age Quiz Is a Window for Drug Makers
by STEPHANIE CLIFFORDNew York Times
March 25th, 2009
RealAge, promising to help shave years off your age, has become one of the most popular quizzes on the Internet. The test asks 150 questions about lifestyle and family history to assign a “biological age." But then pharmaceutical companies pay RealAge to compile test results of RealAge members and send them marketing messages by e-mail.

US: High Court Eases Way to Liability Lawsuits
by Jess BravinWall Street Journal
March 5th, 2009
The Supreme Court said drug makers can be sued in state court over alleged defects, even if the Food and Drug Administration has approved a medication's use. The 6-3 ruling undercuts years of business efforts to block state suits over the safety of products from motorcycle brakes to railway cars.

SWITZERLAND: Davos Scales Back Glitz
by Associated PressNew York Times
January 25th, 2009
The economic crisis that emerged out the collapse of securities based on shaky U.S. mortgages poses challenges for the Davos World Economic Forum, an arena that has championed market-driven approaches.

US: Research Center Tied to Drug Company
by GARDINER HARRISThe New York Times
November 24th, 2008
Court documents reveal that Dr. Joseph Biederman, a renowned child psychiatrist, pushed Johnson & Johnson to fund a research center whose goal was “to move forward the commercial goals of J&J.”

US: Radio Host Has Drug Company Ties
by GARDINER HARRISThe New York Times
November 21st, 2008
An influential psychiatrist who was the host of the popular NPR program “The Infinite Mind” earned at least $1.3 million from 2000 to 2007 giving marketing lectures for drugmakers, income not mentioned on the program.


CorpWatch Blog

The 10 Worst Corporations of 2008
January 9th, 2009

Pharmaceutical Payola -- Drug Marketing to Doctors
by Rob WeissmanMultinational Monitor
May 22nd, 2008
Last week, a hearing of the U.S. Congress House Energy and Commerce Committee's oversight subcommittee focused on advertising campaigns for three drugs, including the remarkable case of Robert Jarvik.

2008 Public Eye Awards
by Pratap Chatterjee
September 27th, 2007

Who's Really Paying the High Prices for Your Pharmaceuticals?
by Stan Cox
September 19th, 2007


CorpWatch Exclusives

Doctoring the Evidence: GlaxoSmithKline Pushes Depression Drug
by Shelley JofreSpecial to Corp Watch
July 30th, 2007
GlaxoSmithKline provides research funding to doctors who write favorable opinions of depression drugs for children, despite evidence from clinical trials that the medication can cause anger and even suicide.

Merck's Murky Dealings: HPV Vaccine Lobby Backfires
by Terry J. AllenSpecial to CorpWatch
March 7th, 2007
Merck's lobbying campaign for mandatory vaccination of school girls provided funding for a prominent women's non-profit. The ensuing uproar has created a backlash against the pharmaceutical giant.

University, Inc.
by Jennifer BordenSpecial to CorpWatch
April 11th, 2005
From research patents to high-stakes partnerships, Jennifer Washburn spent years researching the links between industry and the American University. In this exclusive interview with CorpWatch's Jennifer Borden, Washburn talks about what she found, why it matters and what you can do about it.

Exporting Cures, Importing Misery
by By Stan CoxAlterNet
January 19th, 2005
The Kazipally industrial area – once good farm country – now accounts for more than one-third of India's pharmaceutical industry, meaning skyrocketing rates of cancer, heart disease and birth defects for its residents.

Biotechnology's Third Generation
by Carmelo Ruiz-MarreroSpecial to CorpWatch
April 5th, 2002
From golden rice to anti-viral tomatoes, is the biotech industry's third generation good medicine or good marketing? And, activists ask, what are the environmental consequences?